Single Ascending Dose Challenge Study to Determine Safety and Reactogenicity of an Influenza Challenge Virus

NCT04106817 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
35
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

WCCT Global

Collaborators